课题基金 / 基金详情

California State University - Interdisciplinary Cancer Meeting (CSU-ICM)

California State University - Interdisciplinary Cancer Meeting (CSU-ICM)
加州州立大学 - 跨学科癌症会议 (CSU-ICM)
批准号:
10539868
负责人:
Jonathan Kelber
金额:
$0.5万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-08-01 至 2023-07-31

项目摘要

项目成果

Jonathan Kelber的其他基金

相似基金

相关文献

中文摘要
翻译
R13应用 凯尔伯、塔梅、德·贝拉尔 标题:加州州立大学-跨学科癌症会议(CSU-ICM) 项目摘要 所有癌症类型的平均死亡率保持在30%以上。发展 针对肿瘤学研究中的核心问题,我们已经建立了 两年一度的加州州立大学跨学科癌症会议(CSU-ICM)。 此应用程序将支持2022年肿瘤微环境会议: 挑战与机遇,将于周五举行,10月21日在加州 州立大学北岭,太阳广场表演厅。本次会议讨论了 需要癌症研究会议,提供负担得起的和重点突出的平台, 生命科学家、非生命科学家和癌症专家之间的跨学科交流。 首届2018 CSU-ICM欢迎Joan Brugge博士和150多名与会者。的 由于COVID 19,2020年的第二个CSU-ICM是虚拟的,但取得了巨大成功, 欢迎卡洛斯·阿特阿加博士和70多名与会者。本申请基于 从2018年和2020年的活动中收集的初步数据表明, 在种族、学科、地理和机构各级的参与。我们推测 这次会议的战略扩展将激发新的合作调查路线 这导致了癌症研究的变革性进展,并增加了癌症研究的多样性。 肿瘤学研究简短的谈话会议将由教师领导主持, 围绕培训生演示设计-提高那些 传统上在癌症研究中代表性不足。癌症幸存者的参与- 支持者将强调,即使是最基本的科学研究, 都是基于清晰的个人视角世界知名的全体演讲者确保 最高质量的科学交流。研究生院信息会议将 为本科生和硕士研究生提供一个有形的渠道, 有关计划和应用程序的细节从教师代表有意义的见解,在 顶级R1机构。最后,海报会议旨在促进科学 交流、建立联系的机会和对正在进行的工作的建设性反馈。在 总结,CSU-ICM旨在促进科学知识,学习, 发现;促进专业发展;和准备一个多样化的科学 同时也满足了更广泛的癌症研究的重要需求 社区
英文摘要
R13 Application Kelber, Tamae, De Bellard Title: The California State University – Interdisciplinary Cancer Meeting (CSU-ICM) PROJECT SUMMARY The average mortality across all cancer types remains at over 30%. To develop transformative solutions to central problems in oncology research, we have established the biennial California State University – Interdisciplinary Cancer Meeting (CSU-ICM). This application is to support the 2022 meeting on The Tumor Microenvironment: Challenges and Opportunities that will be held on Friday, October 21 at the California State University Northridge, Plaza del Sol Performance Hall. This meeting addresses the need for cancer research meetings that provide affordable and focused platforms for interdisciplinary exchange between life scientists, non-life scientists and cancer experts. The inaugural 2018 CSU-ICM welcomed Dr. Joan Brugge and over 150 participants. The second CSU-ICM in 2020 was virtual due to COVID19 but was a big success and welcomed Dr. Carlos Arteaga and over 70 participants. This application is based upon preliminary data collected from the 2018 and 2020 events demonstrating diversity of participation at ethnic, discipline, geographic and institute levels. We postulate that strategic expansion of this meeting will stimulate novel, collaborative lines of investigation that lead to transformative advances in cancer research and increase diversity in oncology research. The short talk sessions will be chaired by faculty leaders and designed around trainee presentations - increasing the upward mobility of those traditionally underrepresented in cancer research. Involvement of cancer survivor- advocates will underscore the need to ensure that even the most basic science research is grounded in clear personal perspective. The world-renowned plenary speakers ensure the highest quality of scientific exchange. The graduate school information session will provide a tangible conduit for undergraduate and masters-level graduate students to gain meaningful insights about program and application details from faculty representatives at top-tier R1 institutions. Finally, the poster session is designed to foster scientific exchange, networking opportunities and constructive feedback on work-in-progress. In summary, the CSU-ICM is designed to advance scientific knowledge, learning, and discovery; promotion of professional development; and preparation of a diverse scientific workforce while also fulfilling an important need in the broader cancer research community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Non-Transcriptional Mechanisms of PEAK1 Action During TGFbeta-Induced EMT
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
海外基金